TXN-10128
- Generic Name
- TXN-10128
A Study of TXN10128 in Subjects With Solid Tumors
Phase 1
Recruiting
- Conditions
- Locally Advanced (Unresectable) or Metastatic Solid Tumors
- Interventions
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Txinno Bioscience Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT05978492
- Locations
- 🇰🇷
Gachon University Gil Medical Center, Incheon, Korea, Republic of
🇰🇷Chungbuk National University Hospital, Cheonju, Chungcheongbuk-do, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath